Viewing the Development of the Antihypertensive Drugs in China through Comparison among 6 Editions of New Materia Medica / 中国药房

ABSTRACT

OBJECTIVE: To discuss the development of the antihypertensive drugs in China. METHODS: The varieties of antihypertensive drugs in New Materia Medica from the 11th (1981) to 16th edition (2007) were analyzed statistically. RESULTS & CONCLUSIONS: The antihypertensive drugs in China has experienced a great development ever since 1997 (14th edition) in that the varieties of adrenoreceptor blockers, calcium-channel blocker, angiotensin-converting enzyme inhibitors and Ang Ⅱ receptor blockers had been increased, thus safer and more effective drugs were available for hypertensive patients meanwhile the case fatality was able to be reduced.